Sign in
4

Changes in Ownership

DEXCOM INC Filed Acc 0001093557-24-000049

EVP Strategy and Corporate sold 6,710 shares at $134.41 ($901,896)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dolan Matthew Vincent EVP Strategy and Corporate 2024-03-12 Sale −6,710 $134.41 $901,896 48,570 D: show line 1 in the form
Open-market sales · 6,710 sh · avg $134.41 · $901,896
Loading xslF345X05/edgardoc.xml…